COPA mutations reveal alternative trigger for small intestine tumors
· Medical Xpressedited by Sadie Harley, reviewed by Robert Egan
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Associate Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
A signaling system known as the Wnt pathway plays a central role in how cells in the intestine grow, divide and renew themselves. Decades of research have shown that disruption of this pathway is a defining feature of many intestinal cancers. In particular, mutations in the APC gene—which normally acts as a brake on Wnt signaling—are widely recognized as a key initiating event in colorectal tumors.
Although cancer of the small intestine follows a similar developmental sequence, it is a rare disease, accounting for only 3% of all gastrointestinal cancers. Interestingly, while APC mutations are found in about 90% of small intestinal adenomas (benign), they appear in fewer than 30% of small intestinal adenocarcinomas (malignant form). This discrepancy has long raised an important question: What else is driving tumor formation and cancer progression in these cases?
A research team led by Professor Shigeki Sekine and Professor Toshiro Sato from Keio University School of Medicine, Japan, set out to address this knowledge gap. Their paper, co-authored by Associate Professor Masayuki Fujii and Assistant Professor Naoko Abeto from the same institute, will be published in Nature Genetics.
A new genetic suspect
The study identified recurrent mutations in a gene with no previously known link to cancer as an alternative driver of small intestine tumorigenesis.
The team began by examining a morphologically distinct set of small intestinal adenomas taken from three patients. These adenomas were protruding rather than flat, with branched glands and unusual structural features.
By sequencing the protein-coding regions of the genome in these tumors, the researchers found recurrent deletions in a specific part of a gene called COPA. This gene encodes a component of the coatomer complex, which is involved in transporting proteins between the Golgi apparatus and the endoplasmic reticulum.
To validate this finding, the team screened a broader cohort of small intestinal adenoma and adenocarcinoma cases and identified similar COPA mutations in a fraction of them. Notably, none of these cases carried mutations in APC or other known Wnt pathway genes, confirming that COPA mutations represent a genuinely independent route to tumorigenesis.
"Scientists have exhaustively hunted down genes responsible for cancer, so this was a shocking new find," said Dr. Fujii.
How COPA alters signaling
To understand the functional consequences of these COPA mutations, the team grew small intestinal organoids (3D miniaturized and simplified version of an organ produced in the laboratory) from patient-derived tumor tissue and separately used gene-editing tools to introduce the same COPA mutations into healthy small intestinal organoids.
Both approaches converged on the same result: COPA mutations activate the Wnt pathway in a way that bypasses the normal requirement for R-spondin and Noggin, two key proteins that act as essential amplifiers of Wnt signaling.
Classification and diagnosis implications
This work has important implications for how small intestinal tumors are classified and diagnosed. Compared with colon cancer, the different subtypes of small intestinal adenomas have been difficult to categorize, in part because of their rarity.
"The current discovery could inform catalogs like the WHO classification of digestive system tumors, which doctors widely use to identify tumor types in patients," Fujii said.
Moreover, the findings help explain the previously unresolved gap between the high frequency of APC mutations in small intestinal adenomas and their relative scarcity in adenocarcinomas, suggesting that multiple atypical biological paths drive malignancy in these tissues, with COPA-driven tumorigenesis representing one of them.
The researchers hope that further research on COPA mutations may help in the development of new diagnostic and treatment strategies for intestinal cancers in patients without APC mutations, potentially improving outcomes in this challenging disease.
Publication details
Fujii, M., et al. Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors, Nature Genetics (2026). DOI: 10.1038/s41588-026-02616-9
Journal information: Nature Genetics
Key medical concepts
Wnt Signaling PathwayAPC regulator of WNT signaling pathway
Clinical categories
OncologyGastroenterologyClinical genetics Provided by Keio University Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: COPA mutations reveal alternative trigger for small intestine tumors (2026, June 12) retrieved 12 June 2026 from https://medicalxpress.com/news/2026-06-copa-mutations-reveal-alternative-trigger.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.